Lipid TD5
目录号 : GC92682Lipid TD5 is an ionizable cationic lipid (pKa = 7.3) that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA in vitro and in vivo.
Cas No.:2855180-86-6
Sample solution is provided at 25 µL, 10mM.
Lipid TD5 is an ionizable cationic lipid (pKa = 7.3) that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA in vitro and in vivo. LNPs containing lipid TD5 undergo endocytosis in a serotonin (5-HT) receptor subtype 1A-dependent manner in primary mouse astrocytes. Intrathecal administration of LNPs containing lipid TD5 selectively traffic to the brain over the liver and spleen in mice.
| Cas No. | 2855180-86-6 | SDF | |
| 化学名 | N-[6-(ditetradecylamino)hexyl]-1H-indole-3-propanamide | ||
| Canonical SMILES | O=C(CCC1=CNC2=C1C=CC=C2)NCCCCCCN(CCCCCCCCCCCCCC)CCCCCCCCCCCCCC | ||
| 分子式 | C45H81N3O | 分子量 | 680.163 |
| 溶解度 | Ethanol: Soluble: ≥10 mg/ml | 储存条件 | -20°C |
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.4702 mL | 7.3512 mL | 14.7024 mL |
| 5 mM | 294 μL | 1.4702 mL | 2.9405 mL |
| 10 mM | 147 μL | 735.1 μL | 1.4702 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >90.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
















